Corrigendum to "iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II" [Exp. Cell Res. 412, Issue 1, 1 March 2022, 113007].
Junjie HongYu-Shan ChengShu YangManju SwaroopMiao XuJeanette BeersJizhong ZouWenwei HuangJuan J MaruganXiujun CaiWei ZhengPublished in: Experimental cell research (2023)